— Know what they know.
Not Investment Advice

PRPO NASDAQ

Precipio, Inc.
1W: -12.9% 1M: -21.6% 3M: -13.5% YTD: -20.6% 1Y: -8.0% 3Y: +180.2% 5Y: -62.9%
$18.91
-0.44 (-2.27%)
 
Weekly Expected Move ±5.1%
$18 $19 $20 $21 $22
NASDAQ · Healthcare · Medical - Diagnostics & Research · Tech Score Sell · Power 33 · $33.9M mcap · 1M float · 7.29% daily turnover · Short 36% of daily vol
Credit Risk of going bust: higher than 53% of companies Debt: 9.0% of company value Bonds: none of note held by US funds details ▾
Of US companies ranked in the middle of the pack, about 1 in 580 filed for bankruptcy within a year (2020-2025).
If the stock fell to about $0.27 (down 99%), Precipio, Inc. would be worth roughly what it owes.
Total debt $3.3M against a stock market value of $33.9M.
Distance to default 4.83 (Merton model): prices to 2026-10-27, balance sheet 2026-06-30, debt counted $2.0M (short-term plus half of long-term), stock volatility 60.2%; Altman Z'' -13.13. A ranking and a back-test, not a forecast.
US fund filings (SEC N-PORT) show under $25M of this company's bonds, so there is no bond page. Its debt may be bank loans or privately placed. How these are computed.
0.00
Neutral
0 bullish 0 neutral 0 bearish
Articles (24h)
0
No articles in the last 24 hours
-0.90
Bearish
0 bullish 0 neutral 1 bearish
Articles (7d)
1
Daily Sentiment (7 Days)
Articles (40)
Precipio (NASDAQ:PRPO) Shares Cross Below 200-Day Moving Average – Here’s Why
Bearish DefenseWorld · 4d ago · -0.90
Precipio (NASDAQ:PRPO) Share Price Crosses Below 200 Day Moving Average – What’s Next?
Bearish DefenseWorld · 2w ago · -0.90
PRPO vs. FLGT: Which Cancer Diagnostics Stock Has More Upside Now?
Zacks · 5w ago · 0.00
The Zacks Analyst Blog Highlights Goldman Sachs, RTX, Abbott, NLI and Precipio
Zacks · 6w ago · 0.00
Top Research Reports for Goldman Sachs, RTX & Abbott
Zacks · 6w ago · 0.00
BlackRock Inc. Acquires New Holdings in Precipio, Inc. $PRPO
Bullish DefenseWorld · 7w ago · 0.90
PRPO vs. BDSX: Which Cancer Diagnostics Stock Is the Better Buy Now?
Zacks · 9w ago · 0.00
Precipio Stock Gains Post Q2 Earnings, Revenue Momentum Strong
Bullish Zacks · 9w ago · 0.90
Precipio, Inc. (PRPO) grows Q2 2026 revenue 24% amid going concern warning - Stock Titan
Bearish Google-Earnings · 10w ago · -0.90
Precipio Announces Q2-2026 Financial Results
Bullish GlobeNewsWire-EarningsResults · 10w ago · 0.90
Precipio (NASDAQ:PRPO) Stock Price Passes Below Two Hundred Day Moving Average – Should You Sell?
Bearish DefenseWorld · 12w ago · -0.90
PRPO vs. NEO: Which Cancer Diagnostics Stock Is the Better Buy?
Zacks · 14w ago · 0.00
The Zacks Analyst Blog Highlights Caterpillar, Palo Alto Networks, Toyota Motor and Precipio
Zacks · 17w ago · 0.00
Top Analyst Reports for Caterpillar, Palo Alto & Toyota
Zacks · 17w ago · 0.00
Precipio to Present at the Planet MicroCap Las Vegas
Benzinga-News · 19w ago · 0.00
Precipio (PRPO) Q1 2026 Earnings Call Transcript
MotleyFool · 21w ago · 0.00
Precipio Stock Slips Post Q1 Earnings Despite Revenue Growth
Bearish Zacks · 22w ago · -0.90
Precipio Announces Q1 2026 Financial Results
Benzinga-Earnings · 23w ago · 0.00
Precipio Announces Q1 2026 Financial Results
Bullish GlobeNewsWire-EarningsResults · 23w ago · 0.90
The Zacks Analyst Blog NVIDIA, Mastercard, AbbVie, Waterstone and Precipio
Bullish Zacks · 23w ago · 0.90
Top Stock Reports for NVIDIA, Mastercard & AbbVie
Bullish Zacks · 24w ago · 0.90
Precipio Announces Q1-2026 Shareholder Update Call
Benzinga-News · 24w ago · 0.00
Most and least shorted healthcare stocks with up to $2B market cap in May
SeekingAlpha · 25w ago · 0.00
12 Health Care Stocks Moving In Monday's After-Market Session
Bullish Benzinga-Movers · 27w ago · 0.90
Precipio GAAP EPS of -$0.23, revenue of $24.05M
Bearish SeekingAlpha · 29w ago · -0.90
Here are the major earnings after the close Thursday
SeekingAlpha · 29w ago · 0.00
Earnings Scheduled For April 2, 2026
Benzinga-Earnings · 29w ago · 0.00
Earnings week ahead: NKE, TLRY, SPCE, BYND, NNDM, CAG, and more
SeekingAlpha · 30w ago · 0.00
Precipio Announces Q4 and year-end 2025 Shareholder Update Call
Benzinga-News · 32w ago · 0.00
Precipio Announces Publication of a Joint Study with Memorial Sloan-Kettering Cancer Center Highlighting Its Cutting-Edge Bloodhound BCR::ABL1 Assay
Bullish GlobeNewsWire-FDA · 33w ago · 0.90
Precipio 2025 (Unaudited) Revenues Grew to $24.0M, a 30% Increase Year-Over-Year
Bullish GlobeNewsWire · 34w ago · 0.90
Precipio, Inc. (NASDAQ:PRPO) Short Interest Update
Bearish DefenseWorld · 36w ago · -0.90
Precipio (NASDAQ:PRPO) Stock Price Crosses Below Two Hundred Day Moving Average – Here’s Why
Bearish DefenseWorld · 37w ago · -0.90
Short Interest in Precipio, Inc. (NASDAQ:PRPO) Increases By 21.0%
Bearish DefenseWorld · 39w ago · -0.90
AMH Equity Ltd Grows Holdings in Precipio, Inc. $PRPO
Bullish DefenseWorld · 40w ago · 0.90
Precipio Takes Major Steps Toward a Clean Balance Sheet
Bullish GlobeNewsWire · 40w ago · 0.90
Tivic Health Systems (NASDAQ:TIVC) and Precipio (NASDAQ:PRPO) Head to Head Review
DefenseWorld · 42w ago · 0.00
Precipio to Showcase its BCR::ABL1 panel at 2025 ASH (American Society of Hematology) Meeting
Bullish GlobeNewsWire · 46w ago · 0.90
Precipio Identifies Unauthorized Access to Isolated Storage; No Operational Impact
Bearish GlobeNewsWire · 46w ago · -0.90
Precipio Stock Up Following Solid Q3 Earnings and Improved Cash Flow
Bullish Zacks · 48w ago · 0.90

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms